CN108514610A - A kind of Chinese medicine for treating diabetes - Google Patents
A kind of Chinese medicine for treating diabetes Download PDFInfo
- Publication number
- CN108514610A CN108514610A CN201810422232.4A CN201810422232A CN108514610A CN 108514610 A CN108514610 A CN 108514610A CN 201810422232 A CN201810422232 A CN 201810422232A CN 108514610 A CN108514610 A CN 108514610A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- diabetes
- chinese medicine
- fruit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese medicine, more particularly to a kind of Chinese medicine for treating diabetes is composed of the following raw materials by weight:15 25 parts of American Ginseng, 18 24 parts of Radix Angelicae Sinensis, 18 22 parts of Radix Astragali, 16 22 parts of Radix Rehmanniae, 25 32 parts of radix scrophulariae, 25 32 parts of radix polygonati officinalis, 15 30 parts of campanulaceae, 15 30 parts of radix paeoniae rubra, 24 35 parts of the root bark of white mulberry, 25 35 parts of sealwort, 25 35 parts of giant knotweed, 15 20 parts of Radix Paeoniae Alba, 28 35 parts of wild chrysanthemum, 26 35 parts of the fruit of Chinese wolfberry, 18 22 parts of Fructus Corni, 50 75 parts of Poria cocos, 20 35 parts of Radix Achyranthis Bidentatae, 18 22 parts of the dried immature fruit of citron orange, 15 22 parts of rheum officinale, 10 25 parts of cape jasmine, 15 22 parts of waxgourd peel, 25 40 parts of corn stigma, 1 10 parts of peppermint, 5 15 parts of licorice, 20 35 parts of RHIIZOMA DIOSCOREAE from Henan of China.Compared with prior art, advantageous effect of the present invention is:There is good hypoglycemic effect for diabetes B, bad person is still especially controlled to insulin injection blood glucose target and has more preferable effect, 95% or more clinically may be up to the substitution rate of insulin for diabetes B.
Description
Technical field
The present invention relates to a kind of Chinese medicine, more particularly to a kind of Chinese medicine for treating diabetes.
Background technology
Diabetes are still within the stage occurred frequently in worldwide at present, and China is then the highest country of its incidence
One of." various complication caused by diabetes " more frighteningly are faced, no matter currently, in western developed country or at other
There are no preferable preventive preparations so far in developing country.
Technology should take " emphasis hypoglycemic, comprehensively regulating " as treatment policy sustained improvement at present.All antidiabetic drugs and pancreas islet
Element, main function are the metabolism present situations for reducing patient blood glucose's index and improving sugar, and for other closely related with diabetes
And very important index, such as:Blood pressure, blood fat, cholesterol, whole blood viscosity, liver function, kidney function etc., not only rare effect,
And thering are many drugs to still have more side effect, this is for needing the diabetes patient to take medicine for a long time, especially 2 type of person in middle and old age sugar
It urinates for patient, undoubtedly a kind of fearful chronic, progressive harm, and diabetic complication is caused to be in high incidence
One of main inducing.
Therefore, it is quite necessary to research and develop a kind of new pharmaceutical composition, not only hypoglycemic effect is good, and can also prevent
With the generation for avoiding various complication.
Invention content
The object of the present invention is to provide a kind of Chinese medicine composition that drug resistance is low, can effectively repair improves diabetes patient
Insulin function, eliminate insulin resistance, improve surrounding tissue cells to sugar Absorption And Metabolism, to reduce blood glucose target,
The immunity of human body can also be effectively improved simultaneously, improves the bad disease occurred, and the generation to prevent various complication is beaten
Lower good basis.
To achieve the above object, the technical solution used in the present invention is as follows:
A kind of Chinese medicine for treating diabetes, is composed of the following raw materials by weight:15-25 parts of American Ginseng, 18-24 parts of Radix Angelicae Sinensis,
18-22 parts of Radix Astragali, 16-22 parts of Radix Rehmanniae, 25-32 parts of radix scrophulariae, 25-32 parts of radix polygonati officinalis, 15-30 parts of campanulaceae, 15-30 parts of radix paeoniae rubra, Sang Bai
24-35 parts of skin, 25-35 parts of sealwort, 25-35 parts of giant knotweed, 15-20 parts of Radix Paeoniae Alba, 28-35 parts of wild chrysanthemum, 26-35 parts of the fruit of Chinese wolfberry, mountain
18-22 parts of the fruit of medicinal cornel, 50-75 parts of Poria cocos, 20-35 parts of Radix Achyranthis Bidentatae, 18-22 parts of the dried immature fruit of citron orange, 15-22 parts of rheum officinale, 10-25 parts of cape jasmine, winter
15-22 parts of melon skin, 25-40 parts of corn stigma, 1-10 parts of peppermint, 5-15 parts of licorice, 20-35 parts of RHIIZOMA DIOSCOREAE from Henan of China.
Preferably, a kind of Chinese medicine for treating diabetes, is composed of the following raw materials by weight:15-25 parts of American Ginseng, Radix Angelicae Sinensis 20
Part, 20 parts of Radix Astragali, 20 parts of Radix Rehmanniae, 30 parts of radix scrophulariae, 30 parts of radix polygonati officinalis, 20 parts of campanulaceae, 20 parts of radix paeoniae rubra, 30 parts of the root bark of white mulberry, sealwort 30
Part, 30 parts of giant knotweed, 20 parts of Radix Paeoniae Alba, 30 parts of wild chrysanthemum, 30 parts of the fruit of Chinese wolfberry, 20 parts of Fructus Corni, 60 parts of Poria cocos, 30 parts of Radix Achyranthis Bidentatae,
20 parts of the dried immature fruit of citron orange, 20 parts of rheum officinale, 20 parts of cape jasmine, 20 parts of waxgourd peel, 30 parts of corn stigma, 4 parts of peppermint, 6 parts of licorice, RHIIZOMA DIOSCOREAE from Henan of China 30
Part.
Wherein, to treat capsule or tablet or electuary made of the Chinese medicine of diabetes, it should also within protection domain.
Applicant carried out larger amount of clinical test, during up to clinic trial more than 6 years, according to vast sugar
The generally reflection (referring mainly to reduce hypoglycemic effect and comprehensively regulating effect) for urinating patient has carried out multiple adjustment and improvement.Together
When, side effect that may be present is grasped for verification, applicant has also carried out continuous 5 years tracking and monitorings to clinical user,
Hypoglycemic effect is better than any type hypoglycemic Western medicine, while side effect is again smaller than any type hypoglycemic Western medicine, and comprehensively regulating effect
But it is better than any type Western medicine (including various insulin).
The Chinese medicine for the treatment of diabetes provided by the present invention is by the heart, liver, spleen, lung, the same benefit of kidney the five internal organs, in addition to that can drop blood
Sugar also has effects that nourishing Yin and clearing heat, dampness removing toxin expelling, relaxes bowel, the comprehensively regulatings such as arousing brain, raising spirit.
Compared with prior art, advantageous effect of the present invention is:
1) can effectively repair improves the insulin function of diabetes patient, eliminates insulin resistance, improves surrounding tissue cells
To the Absorption And Metabolism of sugar, to reduce blood glucose target, while the immunity of human body can also be effectively improved, what improvement had occurred
Bad disease lays good basis to prevent various complication;
2) being directed to diabetes B has good hypoglycemic effect, especially still controls bad person to insulin injection blood glucose target
More preferable effect is had, 95% or more clinically may be up to the substitution rate of insulin for diabetes B;
3) extend and avoid the drug resistance generated by Long-term taking medicine human body itself to greatest extent, can drop to greatest extent
The toxic side effect of sinking sugar Western medicine.
Specific embodiment
Present invention is further elaborated in following combination specific embodiment, but should not be taken as to the scope of the present invention
It limits.
A kind of Chinese medicine for treating diabetes, is composed of the following raw materials by weight:15-25 parts of American Ginseng, 20 parts of Radix Angelicae Sinensis, Huang
20 parts of stilbene, 20 parts of Radix Rehmanniae, 30 parts of radix scrophulariae, 30 parts of radix polygonati officinalis, 20 parts of campanulaceae, 20 parts of radix paeoniae rubra, 30 parts of the root bark of white mulberry, 30 parts of sealwort, giant knotweed
30 parts, 20 parts of Radix Paeoniae Alba, 30 parts of wild chrysanthemum, 30 parts of the fruit of Chinese wolfberry, 20 parts of Fructus Corni, 60 parts of Poria cocos, 30 parts of Radix Achyranthis Bidentatae, 20 parts of the dried immature fruit of citron orange,
20 parts of rheum officinale, 20 parts of cape jasmine, 20 parts of waxgourd peel, 30 parts of corn stigma, 4 parts of peppermint, 6 parts of licorice, 30 parts of RHIIZOMA DIOSCOREAE from Henan of China.
Using the Chinese medicine for the treatment of diabetes provided by the present invention, treatment group is divided into 210 Type 2 Diabetes Mellitus in Media-aged Patients people
And control group, and be that basic medicine carries out clinical efficacy contrast test with hypoglycemic Western medicine " diformin tablet (250mg/ pieces) ".
The specific method is as follows:
Control group:105, fasting blood-glucose is in 6.1mmol/L or more, and 7.8mmol/L or less persons, 2 times a day, 1 tablet once.
For fasting blood-glucose index in 7.8mmol/L or more 11.1mmol/L or less persons, noon, which adds, eats a piece of Acarbose (100mg).
Test group:105, the Chinese medicine of the treatment diabetes provided by the technology of the present invention has been added on the basis of the above,
It is taken with pill supply test group, fasting blood-glucose index is in 6.1mmol/L or more, 7.8mmol/L or less persons, 3 times a day, often
Secondary to add 5 balls (per ball 300mg), fasting blood-glucose index is in 7.8mmol/L or more 11.1mmol/L or less persons, 3 times a day, every time
Add 8 balls (per ball 300mg), whole taken with boiled water.
Control group and test group set two months it is as a treatment course.
The result shows that:
The blood glucose target (empty stomach) of 105 people of control group on the basis of the original 90% people have it is different degrees of repeatedly,
Unstable state, and hyperlipidemia is presented, whole blood viscosity is exceeded, coronary heart disease symptom and eye-blurred, dizziness, weak, frequent micturition
Etc. symptoms no changes have been made.
And the blood glucose target for the treatment of group obtains ideal decline, while fasting blood-glucose index is in 6.1mmol/L or more
7.8mmol/L or less persons hypoglycemic Western medicine diformin tablet by it is original twice daily, (250mg) is reduced to often each one
Day primary, 1 tablet once (250mg), at the same by it is early daily, each 1 of evening take mode be adjusted to daily noon take it is a piece of.On an empty stomach
The a piece of Acarbose (100mg) at noon is changed to by blood glucose target in 7.8mmol/L or more 11.1mmol/L or less persons
(50mg), while having deactivated a piece of melbine (250mg) in morning, it was demonstrated that it is provided by the present invention important with certain drop
Hypoglycemia acts on.
In addition, the exceeded state of the hyperlipidemia of test group, whole blood viscosity also obtains different degrees of improvement, in 105
The symptoms such as existing coronary heart disease, dizziness, weak, frequent micturition are also significantly improved, it was demonstrated that provided by the present invention important to drop
While hypoglycemia, also there is different degrees of improvement result to more typical sub-health state and coronary heart disease.
Claims (3)
1. a kind of Chinese medicine for treating diabetes, which is characterized in that be composed of the following raw materials by weight:15-25 parts of American Ginseng, Radix Angelicae Sinensis
18-24 parts, 18-22 parts of Radix Astragali, 16-22 parts of Radix Rehmanniae, 25-32 parts of radix scrophulariae, 25-32 parts of radix polygonati officinalis, 15-30 parts of campanulaceae, radix paeoniae rubra 15-30
Part, 24-35 parts of the root bark of white mulberry, 25-35 parts of sealwort, 25-35 parts of giant knotweed, 15-20 parts of Radix Paeoniae Alba, 28-35 parts of wild chrysanthemum, fruit of Chinese wolfberry 26-
35 parts, 18-22 parts of Fructus Corni, 50-75 parts of Poria cocos, 20-35 parts of Radix Achyranthis Bidentatae, 18-22 parts of the dried immature fruit of citron orange, 15-22 parts of rheum officinale, cape jasmine 10-
25 parts, 15-22 parts of waxgourd peel, 25-40 parts of corn stigma, 1-10 parts of peppermint, 5-15 parts of licorice, 20-35 parts of RHIIZOMA DIOSCOREAE from Henan of China.
2. the Chinese medicine for the treatment of diabetes according to claim 1, which is characterized in that be composed of the following raw materials by weight:West
15-25 parts of American ginseng, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Astragali, 20 parts of Radix Rehmanniae, 30 parts of radix scrophulariae, 30 parts of radix polygonati officinalis, 20 parts of campanulaceae, 20 parts of radix paeoniae rubra, mulberry
White 30 parts of skin, 30 parts of sealwort, 30 parts of giant knotweed, 20 parts of Radix Paeoniae Alba, 30 parts of wild chrysanthemum, 30 parts of the fruit of Chinese wolfberry, 20 parts of Fructus Corni, Poria cocos 60
Part, 30 parts of Radix Achyranthis Bidentatae, 20 parts of the dried immature fruit of citron orange, 20 parts of rheum officinale, 20 parts of cape jasmine, 20 parts of waxgourd peel, 30 parts of corn stigma, 4 parts of peppermint, licorice
6 parts, 30 parts of RHIIZOMA DIOSCOREAE from Henan of China.
3. treating capsule or tablet or electuary made of the Chinese medicine of diabetes described in claims 1 or 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810422232.4A CN108514610A (en) | 2018-05-04 | 2018-05-04 | A kind of Chinese medicine for treating diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810422232.4A CN108514610A (en) | 2018-05-04 | 2018-05-04 | A kind of Chinese medicine for treating diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108514610A true CN108514610A (en) | 2018-09-11 |
Family
ID=63430405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810422232.4A Pending CN108514610A (en) | 2018-05-04 | 2018-05-04 | A kind of Chinese medicine for treating diabetes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108514610A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115814029A (en) * | 2022-11-17 | 2023-03-21 | 杨杰 | A Chinese and western medicinal composition for treating diabetes |
-
2018
- 2018-05-04 CN CN201810422232.4A patent/CN108514610A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115814029A (en) * | 2022-11-17 | 2023-03-21 | 杨杰 | A Chinese and western medicinal composition for treating diabetes |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102274429B (en) | Chinese medicinal composition for treating diabetes | |
CN105125851A (en) | Traditional Chinese medicine treating 2-type diabetes and preparation technology | |
CN103656410A (en) | Traditional Chinese medicine preparation for treating cough and preparation method thereof | |
CN105395706A (en) | Health care product for diabetes | |
CN108514610A (en) | A kind of Chinese medicine for treating diabetes | |
CN109528968A (en) | A kind of Chinese medicine composition and its preparation method and application for treating diabetes B | |
CN100509025C (en) | A medicine for treating diabetes | |
CN101843843A (en) | Chinese medicament for treating diabetes | |
CN107714939A (en) | Traditional Chinese herbal decoction for treating diabetes and preparation method thereof | |
CN106729304B (en) | A kind of Chinese medicine for mitigating fasting or side reaction of dieting and preparation method thereof | |
CN103705727A (en) | Chinese medicinal composition for treating diabetes | |
CN103263580A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
CN103263595A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN108392583A (en) | A kind of Chinese medicine preparation for treating diabetic nephropathy | |
CN102784317B (en) | Traditional Chinese medicine composition for treating aphtha | |
CN106880675A (en) | It is promoting blood circulation and removing obstruction in channels dissipate and preparation method thereof | |
CN106344808A (en) | Compound dendrobium officinale health care product capable of assisting in reducing blood sugar | |
CN105535467A (en) | Traditional Chinese medicine watered pills for treating diabetes | |
CN104758889A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN108653642A (en) | Treat the drug and preparation method thereof of diabetes | |
CN104083601A (en) | Traditional Chinese medicinal preparation for treating diabetes mellitus | |
CN103341108A (en) | Pharmaceutical composite for treating stress urinary incontinence after prostatectomy | |
CN103110807B (en) | Medicine for treating diabetes | |
CN109663113A (en) | A kind of quick-acting cough relief traditional Chinese medicine preparations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180911 |
|
RJ01 | Rejection of invention patent application after publication |